Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent.

This publication has 28 references indexed in Scilit:

• First Serial Assessment at 6 Months and 2 Years of the Second Generation of Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold
  Circulation: Cardiovascular Interventions, 2012
• From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?
  European Heart Journal, 2011
• Delayed Coverage in Malapposed and Side-Branch Struts With Respect to Well-Apposed Struts in Drug-Eluting Stents
  Circulation, 2011
• Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis
  Circulation, 2010
• TAXUS VI final 5-year results: a multicentre, randomised trial comparing polymer-based moderate-release paclitaxel-eluting stent with a bare metal stent for treatment of long, complex coronary artery lesions
  EuroIntervention, 2009
• Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
  The Lancet, 2007
• Incomplete Stent Apposition and Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
  Circulation, 2007
• Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study
  The Lancet, 2007
• Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
  New England Journal of Medicine, 2003
• Exercise-Induced Coronary Artery Vasodilation Is Not Impaired by Stent Placement
  Circulation, 2002